| 10 years of health-care reform in China: progress and gaps in Universal Health Coverage W Yip, H Fu, AT Chen, T Zhai, W Jian, R Xu, J Pan, M Hu, Z Zhou, Q Chen, ... The Lancet 394 (10204), 1192-1204, 2019 | 774 | 2019 |
| Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... Jama 328 (16), 1604-1615, 2022 | 563* | 2022 |
| Systematic review on irrational use of medicines in China and Vietnam W Mao, H Vu, Z Xie, W Chen, S Tang PloS one 10 (3), e0117710, 2015 | 195 | 2015 |
| Complications of diabetes in China: health system and economic implications W Mao, CMW Yip, W Chen BMC public health 19, 1-11, 2019 | 108 | 2019 |
| It is not too late to achieve global covid-19 vaccine equity G Yamey, P Garcia, F Hassan, W Mao, KK McDade, M Pai, S Saha, ... Bmj 376, 2022 | 90 | 2022 |
| Does economic incentive matter for rational use of medicine? China’s experience from the essential medicines program M Chen, L Wang, W Chen, L Zhang, H Jiang, W Mao Pharmacoeconomics 32, 245-255, 2014 | 68 | 2014 |
| Current situation and progress toward the 2030 health-related sustainable development goals in China: a systematic analysis S Chen, L Guo, Z Wang, W Mao, Y Ge, X Ying, J Fang, Q Long, Q Liu, ... PLoS medicine 16 (11), e1002975, 2019 | 67 | 2019 |
| Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China W Mao, S Tang, Y Zhu, Z Xie, W Chen International journal for equity in health 16, 1-12, 2017 | 42 | 2017 |
| Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China S Chen, W Mao, L Guo, J Zhang, S Tang BMJ global health 5 (6), e002306, 2020 | 38 | 2020 |
| People's Republic of China health system review World Health Organization Health systems in transition 5 (7), 2015 | 36 | 2015 |
| Improving Health System Efficiency: China Zero Mark-up for Essential Medicines at Primary Level Facilities W Mao, W Chen | 34* | 2015 |
| Advancing universal health coverage in China and Vietnam: lessons for other countries W Mao, Y Tang, T Tran, M Pender, PN Khanh, S Tang BMC Public Health 20, 1-9, 2020 | 30 | 2020 |
| Under-reporting of TB cases and associated factors: a case study in China D Zhou, M Pender, W Jiang, W Mao, S Tang BMC public health 19, 1-9, 2019 | 28 | 2019 |
| Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis RR Dasgupta, W Mao, O Ogbuoji Malaria Journal 21 (1), 81, 2022 | 26 | 2022 |
| The impacts of donor transitions on health systems in middle-income countries: a scoping review HE Huffstetler, S Bandara, I Bharali, K Kennedy Mcdade, W Mao, F Guo, ... Health Policy and Planning 37 (9), 1188-1202, 2022 | 25 | 2022 |
| Does health insurance impact health service utilization among older adults in urban China? A nationwide cross-sectional study W Mao, Y Zhang, L Xu, Z Miao, D Dong, S Tang BMC health services research 20, 1-9, 2020 | 24 | 2020 |
| Does perverse economic incentive lead to the irrational uses of medicines? W Mao, S Tang, W Chen Expert review of pharmacoeconomics & outcomes research 13 (6), 693-696, 2013 | 24 | 2013 |
| An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China W Mao, Y Huang, W Chen PLoS One 14 (3), e0213638, 2019 | 23 | 2019 |
| Socio-economic and rural-urban differences in healthcare and catastrophic health expenditure among cancer patients in China: analysis of the China health and retirement … Y Zhao, S Tang, W Mao, T Akinyemiju Frontiers in Public Health 9, 779285, 2022 | 20 | 2022 |
| Transitioning from donor aid for health: perspectives of national stakeholders in Ghana W Mao, KK McDade, HE Huffstetler, J Dodoo, DNY Abankwah, ... BMJ Global Health 6 (1), e003896, 2021 | 20 | 2021 |
Osondu OgbuojiDuke University在 duke.edu 的电子邮件经过验证
